Emergent BioSolutions Expands Ready to Rescue Initiative to Support Widespread Opioid Emergency Preparedness
30 août 2024 08h16 HE
|
Emergent BioSolutions
For the second year, Emergent is teaming up with pro football legend, Emmitt Smith, to educate communities on opioid risks and how to be prepared with NARCAN® Nasal SprayIn recognition of...
Mechanism Exchange & Repair Aids in Fighting Opioid Overdoses Through Narcan Distribution Sites
08 déc. 2022 09h00 HE
|
Mechanism Exchange & Repair, Inc.
YOAKUM, Texas, Dec. 08, 2022 (GLOBE NEWSWIRE) -- Mechanism Exchange & Repair, Inc. (MER), one of the last manufacturers of Newspaper Vending Machines, is finding their distribution boxes make...
Fentanyl Drives Fatal Overdoses to Over 107,000 Annually in the U.S. - Healthcare Providers' Effort to Fight Back
24 août 2022 09h00 HE
|
Cordant Health Solutions
PORTLAND, Ore., Aug. 24, 2022 (GLOBE NEWSWIRE) -- Cordant Health Solutions®, a leader in providing innovative tools for addiction treatment programs, is partnering with addiction treatment providers...
Naloxone Spray Global Market is Expected to Reach $785.35 Million in 2025 at a CAGR of 22.3%
29 déc. 2021 05h58 HE
|
Research and Markets
Dublin, Dec. 29, 2021 (GLOBE NEWSWIRE) -- The "Naloxone Spray Global Market Report 2021: COVID-19 Implications and Growth" report has been added to ResearchAndMarkets.com's offering. The global...
Global $3.35 Bn Naloxone (Parenteral, Intranasal, & Sublingual) Markets, 2019-2020 & Forecast to 2027
13 mai 2021 04h43 HE
|
Research and Markets
Dublin, May 13, 2021 (GLOBE NEWSWIRE) -- The "Naloxone Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to...
UPDATE -- Emergent BioSolutions Announces FDA Approval of NARCAN® (naloxone HCl) Nasal Spray Shelf Life Extension to 36 Months
17 août 2020 11h54 HE
|
Emergent BioSolutions
GAITHERSBURG, Md., Aug. 17, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that the U.S. Food and Drug Administration (FDA) has approved the extension of the shelf...
Emergent BioSolutions Announces FDA Approval of NARCAN® (naloxone HCl) Nasal Spray Shelf Life Extension to 36 Months
17 août 2020 06h30 HE
|
Emergent BioSolutions
GAITHERSBURG, Md., Aug. 17, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that the U.S. Food and Drug Administration (FDA) has approved the extension of the shelf...
Emergent BioSolutions Statement on U.S. District Court Decision
05 juin 2020 19h39 HE
|
Emergent BioSolutions
GAITHERSBURG, Md., June 05, 2020 (GLOBE NEWSWIRE) -- Today, the U.S. District Court for the District of New Jersey entered a decision in the patent litigation regarding NARCAN® (naloxone HCl) Nasal...
Emergent BioSolutions to Offer All Public Libraries and YMCAs in the U.S. Free Opioid Awareness Education and NARCAN® (naloxone HCl) Nasal Spray
24 oct. 2018 14h30 HE
|
Emergent BioSolutions
New initiatives make free doses and educational materials available to thousands of public libraries & YMCAs in the U.S. GAITHERSBURG, Md., Oct. 24, 2018 (GLOBE NEWSWIRE) -- Emergent...
Aegis Expands its International and US Intravail® Patent Portfolio on Multiple Fronts
02 août 2018 06h00 HE
|
Aegis Therapeutics LLC
SAN DIEGO, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Aegis Therapeutics LLC announced today that it has been awarded European Patent No. EP2381773(B1) and Canadian Patent No. 2,748,268, providing fast...